Publication | Closed Access

Systematic switch from innovator infliximab to biosimilar infliximab in inflammatory chronic diseases in daily clinical practice: The experience of Cochin University Hospital, Paris, France

InflammationRheumatologyTranslational MedicineEpidemiologyAnti-inflammatoryInflammatory Chronic DiseasesChronic InflammationCochin University HospitalSystematic SwitchInflammatory Rheumatic DiseaseMedicineInflammatory DiseaseRheumatoid Arthritis